Xiaoyan Wu

5.0k total citations · 1 hit paper
31 papers, 3.3k citations indexed

About

Xiaoyan Wu is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Xiaoyan Wu has authored 31 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Xiaoyan Wu's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Influenza Virus Research Studies (4 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaoyan Wu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Influenza Virus Research Studies (4 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaoyan Wu collaborates with scholars based in China, United States and Australia. Xiaoyan Wu's co-authors include Zhibing Lu, Tao He, Hairong Wang, Tao Guo, Yongzhen Fan, Ming Chen, Lin Zhang, Jing Wan, Xinghuan Wang and Dongqing Zha and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoyan Wu

31 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

2020 2.8k citations Tao Guo, Yongzhen Fan et al. profile →

Peers

Countries citing papers authored by Xiaoyan Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaoyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Wu more than expected).

Fields of papers citing papers by Xiaoyan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Wu. The network helps show where Xiaoyan Wu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Wu. A scholar is included among the top collaborators of Xiaoyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Wu. Xiaoyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Foundation Model for Predicting Prognosis and Adjuvant Therapy Benefit From Digital Pathology in GI Cancers 2025 ·Journal of Clinical Oncology ·Xiyue Wang, Yuming Jiang, Sen Yang, Fang Wang, Xiao Ming Zhang, Wei Wang, Yijiang Chen, Xiaoyan Wu, Jinxi Xiang, Yuchen Li, Xiaofeng Jiang, Wei Yuan, Jing Zhang, Kun‐Hsing Yu, Robyn L. Ward, Nicholas J. Hawkins, Jitendra Jonnagaddala, Guoxin Li, Ruijiang Li	6
2	Very severe aplastic anemia in a child with pulmonary mucormycosis: a case report 2024 ·Frontiers in Pediatrics ·(unknown), Nanchuan Jiang, (unknown), Yun Peng, Xiaoyan Wu	1
3	Identification of hub genes in the crosstalk between type 2 diabetic nephropathy and obesity according to bioinformatics analysis 2024 ·Adipocyte ·(unknown), Ke Ding, Feng Chen, Mei Yang, (unknown), Xiaoyan Wu	1
4	The Arabidopsis thaliana integrin-like gene AT14A improves drought tolerance in Solanum lycopersicum 2023 ·Journal of Plant Research ·(unknown), (unknown), Xiaoyan Wu, Bo Yin, Jin Li, Jianbo Zhu	4
5	Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated Patients 2023 ·Current Medical Science ·Zhili Jin, Tao He, Li Peng, Xiaoyan Wu, Di Fan, Ming Chen, Yongzhen Fan, Yuan‐Lin Guo, Zhibing Lu, Hairong Wang	1
6	The automatic detection of diabetic kidney disease from retinal vascular parameters combined with clinical variables using artificial intelligence in type-2 diabetes patients 2023 ·BMC Medical Informatics and Decision Making ·(unknown), (unknown), Juan Zhang, Baifang Zhang, Jing Xiao, (unknown), (unknown), Lihua Ni, Xiaoyan Wu	8
7	Effect and mechanism of action in vitro of cyclodextrin derivative nanoparticles loaded with tyroserleutide on hepatoma 2021 ·Nanotechnology ·Xiaoyan Wu, (unknown), (unknown), (unknown), Zhongjie Wang, Liefeng Zhang, Jing Wang	6
8	Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy 2021 ·Diabetes Metabolic Syndrome and Obesity ·Zhiqin Zhang, Lihua Ni, Lian Zhang, Dongqing Zha, Chun Hu, Lingli Zhang, Huiling Feng, (unknown), Xiaoyan Wu	26
9	MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway 2021 ·Annals of Translational Medicine ·Jie Zhang, Haixia Wang, (unknown), Peng Zhao, Xiaoyan Wu	6
10	Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study 2020 ·Frontiers in Medicine ·Yongzhen Fan, Tao Guo, Feifei Yan, Ming Gong, Xin A. Zhang, Chenze Li, Tao He, (unknown), Lin Zhang, Ming Chen, Xiaoyan Wu, Hairong Wang, Ke‐Qiong Deng, (unknown), Lin Cai, Zhibing Lu	25
11	Telmisartan attenuates diabetic nephropathy progression by inhibiting the dimerization of angiotensin type-1 receptor and adiponectin receptor-1 2019 ·Life Sciences ·Dongqing Zha, Tao Yao, Liping Bao, Ping Gao, Xiaoyan Wu	10
12	Relation of neutrophil-to-lymphocyte ratio to acute kidney injury in patients with sepsis and septic shock: A retrospective study 2019 ·International Immunopharmacology ·(unknown), Lian Zhang, (unknown), Xiaoyan Wu	57
13	A Sensitive Nano Luciferase Immune Complex Assay System for Highly Sensitive and Specific Detection of Antibodies Against Tick-Borne Encephalitis Virus 2018 ·Vector-Borne and Zoonotic Diseases ·Yuchang Li, Yi Hu, Xiaoyan Wu, (unknown), Jing Li, Sen Zhang, Tao Jiang, Xiaoping Kang	1
14	High glucose instigates tubulointerstitial injury by stimulating hetero-dimerization of adiponectin and angiotensin II receptors 2017 ·Biochemical and Biophysical Research Communications ·Dongqing Zha, (unknown), Weiwei Li, (unknown), Xiaoning Li, Lian Zhang, Ying‐Hong Feng, Xiaoyan Wu	19
15	Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential 2017 ·Endocrinology ·Dongqing Zha, Xiaoyan Wu, Ping Gao	82
16	Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells 2017 ·PLoS ONE ·Yuanyuan Wang, Juan Zhang, Lian Zhang, Ping Gao, Xiaoyan Wu	20
17	H5N1 influenza A virus with K193E and G225E double mutations in haemagglutinin is attenuated and immunogenic in mice 2015 ·Journal of General Virology ·Pengfei Han, Jing Li, Yi Hu, Wei Sun, Sen Zhang, Yinhui Yang, Yuchang Li, Xiaoping Kang, Xiaoyan Wu, Shun-Ya Zhu, Yu Zhang, Qingyu Zhu, Cheng‐Feng Qin, Tao Jiang	5
18	U4 at the 3′ UTR of PB1 Segment of H5N1 Influenza Virus Promotes RNA Polymerase Activity and Contributes to Viral Pathogenicity 2014 ·PLoS ONE ·Wei Sun, Jing Li, Pengfei Han, Yinhui Yang, Xiaoping Kang, Yuchang Li, Jiaming Li, Yu Zhang, Xiaoyan Wu, Tao Jiang, Cheng‐Feng Qin, Yi Hu, Qingyu Zhu	11
19	Fluvastatin inhibits angiotensin II-induced nuclear factor kappa B activation in renal tubular epithelial cells through the p38 MAPK pathway 2011 ·Molecular Biology Reports ·Ping Gao, Xiaoyan Wu, Hua Shui, Ruhan Jia	3
20	Expression of adiponectin and its receptors in livers of morbidly obese patients with non‐alcoholic fatty liver disease 2008 ·Journal of Gastroenterology and Hepatology ·Hong Ma, Victoria Gómez, Liang Lu, (unknown), Xiaoyan Wu, Shu‐Yuan Xiao	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuli Cai Breakdown of academic impact, for papers by Jing Wan Breakdown of academic impact, for papers by Yongzhen Fan Breakdown of academic impact, for papers by Mu Qin Breakdown of academic impact, for papers by Ian Huang Breakdown of academic impact, for papers by Ying‐Ying Zheng Breakdown of academic impact, for papers by Qiurong Ruan Breakdown of academic impact, for papers by Gabriel Sayer